A fast-growing dynamic security solutions company is looking to recruit home based sales executives to join their expanding sales division. Due to a steep increase in business growth and incoming enquiries the company is seeking Sales
Any stock covid related seems to be gathering interest. Another interesting one is IMM with lots in its portfolio. It is also working on covid treatment of some sort...
The Company through its subsidiary UREkA Pharma has recently become a partner in a consortium dedicated to the development of novel peptides intended to block the fusion of COVID-19 and other viruses to the target cell, an approach similar to Fuzeon (enfuvirtide) by Roche.
Drugs that target viral entry into the host cell have been proven effective against a wide range of viral diseases. The aim is to apply the results of fundamental research to the development of novel inhibitors of SARS-CoV-2 entry into target cells using the Urelix(TM) patented technology of UREkA Pharma together with contributions from the other members of the consortium. The strategy is based on inhibiting viral entry, using peptides specific for the viral fusion protein.